Sign in

CIK 0001821825

  • Large accelerated filer

Organon & Co.

Sign in to watch
Ticker
OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
464838035
Phone
+1 551-430-6000
Business address
30 HUDSON STREET, FL 33, JERSEY CITY, NJ, 07302
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-05 Stahler Rachel A Chief Information Officer Option exercise +12,890 23,366
2022-08-05 Stahler Rachel A Chief Information Officer Shares withheld for taxes −4,416 $32.41 $143K 18,950
2022-08-05 Stahler Rachel A Chief Information Officer Option exercise · Restricted Stock Units −12,890 12,890
2022-08-05 WALSH MATTHEW M Chief Financial Officer Option exercise +22,343 42,496
2022-08-05 WALSH MATTHEW M Chief Financial Officer Shares withheld for taxes −10,790 $32.41 $350K 31,706
2022-08-05 WALSH MATTHEW M Chief Financial Officer Option exercise · Restricted Stock Units −22,343 22,343
2022-06-10 Whiteford Grace Puma Director Grant or award · Phantom Stock +5,640 $35.46 $200K 14,638
2022-06-10 Sharp Shalini Director Grant or award · Phantom Stock +5,640 $35.46 $200K 14,935
2022-06-10 Patton Cynthia M Director Grant or award · Phantom Stock +5,640 $35.46 $200K 14,638
2022-06-10 Ozuah Phillip Director Grant or award · Phantom Stock +5,640 $35.46 $200K 14,638

Page 33 of 33 · 650 trades